tmem256 Antibody

What is TMEM256 and why is it significant for research?

TMEM256 (Transmembrane protein 256), also known as C17orf61, is a membrane-localized protein with a molecular weight of 11.7 kDa and 113 amino acid residues in its canonical form in humans . Its significance lies in its role as a membrane protein, which makes it potentially important in cellular signaling, transport, and other membrane-associated processes. While less characterized than some other transmembrane proteins, its evolutionary conservation across species including mouse, rat, bovine, zebrafish, and chimpanzee suggests important biological functions . The increasing research interest in TMEM family proteins in disease contexts, particularly cancer, makes TMEM256 a relevant target for investigation .

What applications are TMEM256 antibodies typically used for?

TMEM256 antibodies are primarily used in several experimental techniques:

These applications allow researchers to detect endogenous levels of total TMEM256 protein . Some antibodies are specifically validated for detecting human TMEM256, though reactivity with orthologs may vary between antibody products .

What are the key considerations when selecting a TMEM256 antibody?

When selecting a TMEM256 antibody for research, consider:

• Host species and clonality: Most available antibodies are rabbit polyclonal

• Immunogen details: Some are raised against specific regions (e.g., residues 30-63AA or C-terminal regions)

• Validated applications: Confirm the antibody has been validated for your intended application (ELISA, IF, IHC)

• Species reactivity: Most are optimized for human samples, but cross-reactivity with other species should be verified

• Storage conditions: Typically stored at -20°C or -80°C to maintain activity

• Conjugation status: Available as unconjugated or conjugated (e.g., FITC) for specific applications

Selecting an antibody with proven specificity for your application and species of interest is critical for obtaining reliable results.

How should TMEM256 antibodies be stored and handled?

Proper storage and handling of TMEM256 antibodies are critical to maintaining their activity:

• Storage temperature: Store at -20°C or -80°C as specified by the manufacturer

• Avoid repeated freeze-thaw cycles: Aliquot antibodies upon receipt to minimize degradation

• Working solution preparation: Dilute in appropriate buffer, typically PBS with carrier protein

• Shipping conditions: Typically shipped with ice packs or dry ice; verify integrity upon arrival

• Formulation considerations: Many are supplied in buffers containing glycerol (up to 50%) and preservatives like proclin or sodium azide

Following manufacturer-specific recommendations for handling preservative-containing solutions is essential for both antibody integrity and researcher safety.

What protocols optimize TMEM256 detection in immunofluorescence applications?

For optimal TMEM256 detection in immunofluorescence applications:

• Fixation method: 4% paraformaldehyde (10-15 minutes at room temperature) preserves membrane proteins while maintaining cellular architecture

• Permeabilization: Gentle detergent treatment (0.1-0.3% Triton X-100 for 10 minutes) enables antibody access to membrane proteins

• Blocking solution: 5% normal serum (from species unrelated to primary and secondary antibodies) with 1% BSA reduces background

• Primary antibody incubation: Overnight at 4°C at dilutions typically between 1:100-1:500

• Washing steps: At least 3 washes with PBS-T (PBS + 0.05% Tween-20) for 5 minutes each

• Counterstaining: DAPI (1:1000) for nuclei visualization

• Controls: Include a negative control (omitting primary antibody) and positive control tissue

For co-localization studies with other membrane markers, sequential staining protocols may be necessary to avoid cross-reactivity.

How can researchers troubleshoot non-specific binding when using TMEM256 antibodies?

When encountering non-specific binding with TMEM256 antibodies:

• Titrate antibody concentration: Test multiple dilutions to identify optimal signal-to-noise ratio

• Optimize blocking conditions: Increase blocking time (1-2 hours) or concentration (up to 10% serum)

• Add protein competitors: Add 1-5% BSA to blocking and antibody dilution buffers

• Increase wash stringency: Use higher salt concentration (up to 500mM NaCl) in wash buffers

• Pre-absorb antibody: Incubate with non-target tissue lysate to remove cross-reactive antibodies

• Validate specificity: Use siRNA knockdown controls to confirm signal specificity

• Compare multiple antibodies: Test antibodies from different vendors or those recognizing different epitopes

For polyclonal antibodies, batch-to-batch variation may occur, necessitating validation with each new lot .

What are the advantages and limitations of using recombinant vs peptide-generated TMEM256 antibodies?

Understanding the differences between recombinant and peptide-generated TMEM256 antibodies is crucial for experimental design:

TMEM256 antibodies are available in both formats, with recombinant antibodies using human TMEM256 protein fragments (e.g., residues 30-63AA) and peptide antibodies typically targeting C-terminal regions . The choice depends on research requirements, with recombinant antibodies offering higher consistency for longitudinal studies and peptide antibodies sometimes providing cost advantages for short-term projects.

How can TMEM256 detection be incorporated into multi-parameter flow cytometry panels?

For incorporating TMEM256 detection into multi-parameter flow cytometry:

• Panel design considerations:

  • Select a fluorophore-conjugated TMEM256 antibody (e.g., FITC) with minimal spillover into other channels

  • Position TMEM256 in a channel with appropriate brightness for expected expression level

  • Include compensation controls for each fluorophore

• Sample preparation optimization:

  • Gentle cell dissociation methods to preserve membrane proteins

  • Fixation with 2% paraformaldehyde if intracellular staining is required

  • Consider sequential staining for mixed surface/intracellular panels

• Gating strategy:

  • Include isotype control for setting TMEM256 positivity threshold

  • Use known positive and negative cell populations as controls

  • Consider viability dye to exclude dead cells which may bind antibodies non-specifically

• Data analysis approach:

  • Quantify as percentage positive and/or median fluorescence intensity

  • Consider dimensionality reduction techniques (tSNE, UMAP) for complex panels

  • Correlate TMEM256 expression with other cellular markers

This approach enables analysis of TMEM256 expression in heterogeneous cell populations and correlation with other cellular parameters.

What controls are essential when using TMEM256 antibodies in research?

A robust experimental design with TMEM256 antibodies requires several types of controls:

• Negative controls:

  • Isotype control antibody (same species, isotype, and concentration as TMEM256 antibody)

  • Secondary antibody-only control (omitting primary antibody)

  • Known TMEM256-negative tissues or cell lines

• Positive controls:

  • Tissues or cell lines with validated TMEM256 expression

  • Recombinant TMEM256 protein for western blot or ELISA standard curves

• Specificity validation controls:

  • siRNA knockdown of TMEM256 (e.g., using sequences like 5'−GCAGCCAAATGTGGTCTCA-3')

  • Blocking peptide competition assay

  • Multiple antibodies targeting different TMEM256 epitopes

• Technical controls:

  • Loading controls (e.g., GAPDH) for western blots

  • Peptide absorption controls for immunohistochemistry

  • RT-qPCR validation of expression at mRNA level (primers: forward 5'-GCAGCCAAATGTGGTCTCATCC-3', reverse 5'-GCAAAAGACGGACAGGATGACC-3')

Implementing these controls ensures reliable interpretation of experimental results and helps distinguish true signal from artifacts.

How should researchers design experiments to assess TMEM256 function in cellular processes?

To investigate TMEM256 function in cellular processes:

• Expression modulation approaches:

  • Knockdown using validated siRNAs (multiple sequences recommended)

  • Overexpression using expression vectors with appropriate tags

  • CRISPR/Cas9 gene editing for knockout or precise mutations

• Functional readouts:

  • Membrane integrity assays

  • Cell proliferation and viability measurements

  • Migration and invasion assays in cancer cell models

  • Protein-protein interaction studies (co-IP, proximity ligation)

  • Subcellular localization analysis via fractionation or imaging

• Context-dependent assessments:

  • Cell type-specific effects (epithelial vs. immune cells)

  • Response to cellular stressors (hypoxia, nutrient deprivation)

  • Relationship to other TMEM family members

• Data integration:

  • Correlate functional outcomes with expression levels

  • Compare effects across multiple cell lines and conditions

  • Use pathway analysis to identify affected networks

This comprehensive approach allows researchers to build a mechanistic understanding of TMEM256's role in normal and pathological processes.

What is the significance of TMEM256 in relation to other TMEM family proteins in disease research?

While specific research on TMEM256 in disease contexts is limited, insights can be drawn from studies of TMEM family proteins:

• Cancer relevance:

  • TMEM family proteins (e.g., ANO1, TMEM59, TMEM204, TMEM205, TMEM92) show altered expression in pancreatic ductal adenocarcinoma (PDAC)

  • Expression patterns correlate with patient survival and response to therapy

  • Several TMEM proteins regulate cancer cell proliferation, migration, and invasion

• Comparative analysis:

  • TMEM proteins share structural similarities but often have diverse functions

  • Expression patterns may be tissue-specific or ubiquitous

  • Some family members function in immune response regulation

• Research approach:

  • Analyze TMEM256 expression across cancer databases (e.g., TCGA)

  • Compare with other TMEM family members using machine learning algorithms

  • Investigate co-expression networks to identify functional relationships

• Therapeutic implications:

  • Altered expression of TMEM proteins may serve as prognostic biomarkers

  • Potential for targeted therapies based on TMEM expression profiles

  • Role in response to immune checkpoint inhibitors and other treatments

Understanding TMEM256 in the context of the broader TMEM family provides valuable insights into potential disease mechanisms and therapeutic targets.

How can researchers quantify TMEM256 expression in immunohistochemistry studies?

For accurate quantification of TMEM256 expression in immunohistochemical studies:

• Scoring methodology:

  • Use a combined scoring system that assesses both staining intensity and percentage of positive cells

  • Intensity scoring: 0 (no pigment), 1 (light yellow), 2 (brownish-yellow), and 3 (dark brown)

  • Percentage scoring: 0 (0-25%), 1 (26-50%), 2 (51-75%), and 3 (>75%)

  • Calculate final score as intensity score × percentage score or as a sum

• Analysis approaches:

  • Manual scoring by multiple blinded observers

  • Digital image analysis using software like QuPath, ImageJ, or HALO

  • Machine learning-based classification for large sample sets

• Statistical considerations:

  • Define positive/negative threshold based on control tissues

  • Compare expression across different tissue types or disease states

  • Correlate with clinical parameters using appropriate statistical tests

• Reporting standards:

  • Document antibody details, dilution, antigen retrieval method

  • Include representative images of scoring categories

  • Report both raw scores and interpreted results (high/low expression)

This systematic approach enables reliable quantification and comparison of TMEM256 expression across different studies and samples.

What bioinformatic approaches can help interpret TMEM256 expression data in single-cell and bulk RNA sequencing studies?

For comprehensive analysis of TMEM256 expression in sequencing data:

• Bulk RNA sequencing analysis:

  • Differential expression analysis between conditions using DESeq2 or Limma packages

  • TPM (Transcripts Per Million) normalization for cross-sample comparisons

  • Correlation with clinical outcomes using Cox regression models

  • Co-expression network analysis to identify functional modules

• Single-cell RNA sequencing approaches:

  • Cell clustering and annotation using markers for major cell types

  • Analysis of TMEM256 expression across identified cell clusters

  • Trajectory analysis to examine expression changes during cellular differentiation or disease progression

  • Integration of multiple datasets using batch correction methods

• Integrated analysis:

  • Correlation between protein expression (antibody-based) and mRNA levels

  • Machine learning models combining expression with other features for outcome prediction

  • Pathway enrichment analysis to identify biological processes associated with TMEM256

• Visualization approaches:

  • UMAP or t-SNE plots for dimensionality reduction and visualization

  • Heatmaps for comparative expression across samples and conditions

  • Forest plots for hazard ratios in survival analyses

These approaches enable researchers to extract meaningful biological insights from complex TMEM256 expression datasets.

How can researchers validate contradictory results when studying TMEM256 across different experimental platforms?

When faced with contradictory results regarding TMEM256:

• Technical validation strategies:

  • Compare multiple antibodies recognizing different epitopes

  • Validate at both protein level (western blot, IHC) and mRNA level (RT-qPCR)

  • Perform spike-in controls with recombinant protein

  • Check for potential isoforms or post-translational modifications

• Biological validation approaches:

  • Test in multiple cell lines or tissue types

  • Compare results across species (if orthologs are available)

  • Use both gain-of-function and loss-of-function studies

  • Examine expression in different physiological or stress conditions

• Methodology considerations:

  • Evaluate sensitivity limitations of each technique

  • Consider temporal differences in expression

  • Assess subcellular localization specificity

  • Review batch effects or experimental variables

• Literature assessment:

  • Perform systematic review of published data

  • Contact authors of contradictory studies for clarification

  • Consider publication bias in reported results

Systematic investigation of contradictory results often leads to deeper insights into context-dependent protein behavior and technical limitations of different detection methods.

How can TMEM256 antibodies be utilized in proximity ligation assays to identify interaction partners?

Proximity ligation assay (PLA) offers powerful capabilities for investigating TMEM256 protein interactions:

• Experimental design considerations:

  • Pair TMEM256 antibody with antibodies against suspected interaction partners

  • Select antibodies from different host species (e.g., rabbit anti-TMEM256 with mouse anti-partner)

  • Include appropriate controls (single antibody, known interactors, non-interactors)

• Optimization steps:

  • Test antibody performance individually in immunofluorescence first

  • Optimize fixation to preserve membrane protein interactions (mild fixation preferred)

  • Determine optimal antibody dilutions specifically for PLA (often more dilute than for standard IF)

• Analysis approach:

  • Quantify PLA signals per cell using specialized image analysis software

  • Compare signal distribution relative to cellular compartments

  • Analyze signal proximity to other labeled structures

• Validation strategies:

  • Confirm interactions using orthogonal methods (co-IP, FRET)

  • Use siRNA knockdown of TMEM256 to verify specificity

  • Test interaction under different physiological conditions

This approach enables detection of endogenous protein-protein interactions in situ without protein overexpression or tags, providing insights into TMEM256's physiological interaction network.

What considerations should guide researchers integrating TMEM256 into multi-omics studies?

For successful integration of TMEM256 into multi-omics research:

• Cross-platform data alignment:

  • Map protein detection (antibody-based) to transcriptomic data

  • Account for temporal differences between mRNA and protein expression

  • Consider post-translational modifications not captured at RNA level

• Functional network construction:

  • Integrate TMEM256 into protein-protein interaction networks

  • Analyze co-expression patterns across -omics layers

  • Identify regulatory relationships using causal network analysis

• Technical considerations:

  • Select compatible sample preparation methods across platforms

  • Implement batch correction and normalization strategies

  • Develop integrated visualization approaches

• Validation strategy:

  • Design targeted validation experiments for key findings

  • Use orthogonal methods to verify cross-platform observations

  • Implement machine learning approaches to integrate diverse data types

This integrated approach provides a comprehensive understanding of TMEM256's role within the broader cellular context and reveals potential functional relationships not evident in single-omics studies.

How can researchers develop quantitative assays for measuring TMEM256 levels in biological samples?

Developing robust quantitative assays for TMEM256:

• ELISA development considerations:

  • Use purified recombinant TMEM256 protein for standard curve generation

  • Select capture and detection antibodies recognizing distinct epitopes

  • Optimize sample preparation to solubilize membrane proteins effectively

  • Validate assay linearity, precision, accuracy, and detection limits

• Mass spectrometry approach:

  • Identify reliable proteotypic peptides unique to TMEM256

  • Develop targeted MS methods (PRM or MRM) for specific detection

  • Use isotope-labeled standards for absolute quantification

  • Optimize membrane protein extraction protocols

• Flow cytometry quantification:

  • Use antibodies with defined binding capacity

  • Implement calibration with beads of known antibody binding capacity

  • Convert fluorescence intensity to molecules of equivalent soluble fluorochrome (MESF)

  • Develop standardized protocols across instruments and facilities

• Digital PCR for transcript quantification:

  • Design primers spanning exon junctions for specificity

  • Use absolute quantification approach with appropriate controls

  • Correlate with protein levels to understand expression regulation

These quantitative approaches enable precise measurement of TMEM256 levels across different sample types and experimental conditions, facilitating comparison between studies and laboratories.